期刊文献+

核心组蛋白分子过乙酰化与慢性阻塞性肺疾病糖皮质激素抵抗 被引量:3

Histone acetylation related to corticosteroid resistance in chronic obstructive pulmonary disease
下载PDF
导出
摘要 染色体核心组蛋白分子作为各种炎症因子和炎症信号转导的关键性终端蛋白质分子,具有基因转录“开关”分子的功能,其活性受组蛋白转乙酰酶/脱乙酰酶(HAT/HDAC)的调节。HAT活性增高,组蛋白分子过乙酰化,DNA表现为解链效应,促进基因转录;而HDAC活性增高则出现相反的效应,基因转录变沉默。HAT和HDAC的动态平衡对基因的转录活性和炎症反应程度的调节起关键作用。慢性阻塞性肺疾病(COPD)肺部氧化应激反应的持续存在,明显降低了肺组织HDAC酶的活性,组蛋白乙酰化/去乙酰化平衡被打破,组蛋白分子过乙酰化、炎症蛋白基因的转录和炎症蛋白的合成得到加强,阻断了糖皮质激素的抗炎症反应效应。小剂量氨茶碱恢复COPD肺组织HDAC活性,减少炎症介质和细胞因子合成和释放,能够改善气道炎症对糖皮质激素治疗的反应性。 Core histone around which DNA is wound plays akey role as a terminal protein of inflammatory signal transducfion on gene transcription. Acetylation of core histone opens up the chromatin structure allowing gene transcription and synthesis of inflammatory proteins to proceed, whereas deacetylated histone reverses this process and switches off inflammatory gene transcription. The balance between histone acetyl-transferase (HAT) and deacetyiase (HDAC) determines the state of histone acetylation. In COPD, oxidants from cigarette smoke or inflammatory cells modify and deactivate HDAC in lung macrophages, and attenuate corticosteroid inhibition of inflammatory cytokines-stimulated histone acetylation and prompt inflammatory gene transcription. Low-dose theophylline induces HDAC activity in epithelial cells and macrophages in lung tissue, and decreases inflammatory gene expression and restores corticosteroid responses in COPD.
作者 王华 陈荣昌
出处 《国际病理科学与临床杂志》 CAS 2006年第6期495-498,共4页 Journal of International Pathology and Clinical Medicine
关键词 慢性阻塞性肺疾病 组蛋白分子乙酰化/去已酰化反应 糖皮质激素抵抗 chronic pulmonary disease, obstructive histone acetylation/deacetylation corticosteroid resistance
  • 相关文献

参考文献19

  • 1Saetta M,Turato G,Maestrelli P,et al.Cellular and structural bases of chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,163:1304-1309.
  • 2Barnes P J,Ito K,Adcock I M.Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase[J].Lancet,2004,363(9410):731-733.
  • 3Annemieke J M,De Ruijter,Albert H,et al.Histone deacetylases (HDACs):characterization of the classical HDAC family[J].Biochem,2003,370(pt3):737-749.
  • 4Cosio B G,Mann B,Ito K,et al.Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma[J].Am J Respir Crit Care Med,2004,170(2):141-147.
  • 5Pelaia G,Vatrella A,Cuda G,et al.Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases[J].Life Sci,2003,72(14):1549-1561.
  • 6Ito K,Chung K F,Adcock I M.Update on glucocorticoid action and resistance[J].J Allergy Clin Immunol,2006,117(3):522-543.
  • 7Cosio B G,Torrego A,Adcock I M.Molecular mechanisms of glucocorticoids[J].Arch Bronconeumol,2005,41(1):34-41.
  • 8Ito K,Barnes P J,Adcock I M.Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12[J].Mol Cell Biol,2000,20(18):6891-6903.
  • 9Ito K,Jazwari E,Cosio B,et al.p65-activated histone acetyltransferase activity is repressed by glucocorticoids:Mifepristone fails to recruit HDAC2 to the p65/HAT complex[J].J BiolChem,2001,276(32):30208-30215.
  • 10Kagoshima M,Ito K,Cosio B,et al.Glucocorticoid suppression of nuclear factor-kappa B:a role for histone modifications[J].Biochem Soc Trans,2003,31(Pt 1):60-65.

同被引文献17

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部